In atopic dermatitis models, ligustilide up-regulates filaggrin and SPTLC1, and reduces tumor necrosis factor-α (TNF-α), interferon-γ, and interleukin-6 (IL-6) to reinforce skin barrier function [10]. This evidence concerns the gene TNF and atopic eczema.